GSK has set new performance share awards for its senior leaders for 2026, with vesting period from 2026 to 2028. These awards are heavily weighted on relative Total Shareholder Return (TSR), alongside specific targets for sales, profit, pipeline sustainability and ESG metrics. This strategy aims to align executive compensation with the company’s long-term growth, R&D effectiveness, and responsible business practices.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
GSK Ties 2026 Executive Share Awards to Growth, Pipeline and TSR Benchmarks
GSK has set new performance share awards for its senior leaders for 2026, with vesting period from 2026 to 2028. These awards are heavily weighted on relative Total Shareholder Return (TSR), alongside specific targets for sales, profit, pipeline sustainability and ESG metrics. This strategy aims to align executive compensation with the company’s long-term growth, R&D effectiveness, and responsible business practices.